Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators
- 30 November 2008
- journal article
- review article
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 79 (3-5), 157-163
- https://doi.org/10.1016/j.plefa.2008.09.012
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genusBritish Journal of Pharmacology, 2008
- Lipoxin A4stable analogs reduce allergic airway responsesviamechanisms distinct from CysLT1 receptor antagonismThe FASEB Journal, 2007
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processingThe Journal of Experimental Medicine, 2007
- Lipoxin A4 inhibits acute edema in mice: Implications for the anti-edematogenic mechanism induced by aspirinProstaglandins & Other Lipid Mediators, 2006
- Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitisProceedings of the National Academy of Sciences of the United States of America, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- A novel rat lipoxin A4 receptor that is conserved in structure and functionBritish Journal of Pharmacology, 2003
- Lipoxin biosynthesis and its impact in inflammatory and vascular eventsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994